Act Advisors, Llc. Pfizer Inc Transaction History

Act Advisors, Llc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $3,340 - $4,360	80 Added 0.75%	10,816 $554,000
Q3 2022 Oct 06, 2022	SELL	$43.76 - $53.42 $5,076 - $6,196	-116 Reduced 1.07%	10,736 $470,000
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $2,884 - $3,420	-62 Reduced 0.57%	10,852 $569,000
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $4,346 - $5,385	-95 Reduced 0.86%	10,914 $565,000
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $10,784 - $15,986	261 Added 2.43%	11,009 $650,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $359,735 - $457,434	10,748 New	10,748 $396,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Act Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Act Advisors, Llc. with notifications on news.